Advertisement
UK markets open in 4 minutes
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,942.94
    +405.13 (+2.19%)
     
  • CRUDE OIL

    79.91
    +0.65 (+0.82%)
     
  • GOLD FUTURES

    2,371.70
    +31.40 (+1.34%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • Bitcoin GBP

    50,361.87
    +1,237.54 (+2.52%)
     
  • CMC Crypto 200

    1,352.00
    -6.01 (-0.44%)
     
  • NASDAQ Composite

    16,346.26
    +43.46 (+0.27%)
     
  • UK FTSE All Share

    4,558.37
    +14.13 (+0.31%)
     

Why Clovis Oncology Zoomed 30% Higher Today

Why Clovis Oncology Zoomed 30% Higher Today

Cancer-focused biotech Clovis Oncology (NASDAQ: CLVS) was a stock on fire Monday. On Sunday, Clovis reported that Rubraca tested very well as a monotherapy for ovarian cancer in the initial part of a phase 3 trial. All told, 538 women suffering from high-grade ovarian, fallopian tube, or primary peritoneal cancer took part in the trial.